Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Nakamura, Ichiro, Maegawa, Hiroshi, Tobe, Kazuyuki, Uno, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479031/
https://www.ncbi.nlm.nih.gov/pubmed/34463953
http://dx.doi.org/10.1007/s13300-021-01134-7
_version_ 1784576160911327232
author Nakamura, Ichiro
Maegawa, Hiroshi
Tobe, Kazuyuki
Uno, Satoshi
author_facet Nakamura, Ichiro
Maegawa, Hiroshi
Tobe, Kazuyuki
Uno, Satoshi
author_sort Nakamura, Ichiro
collection PubMed
description
format Online
Article
Text
id pubmed-8479031
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-84790312021-10-08 Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM Nakamura, Ichiro Maegawa, Hiroshi Tobe, Kazuyuki Uno, Satoshi Diabetes Ther Correction Springer Healthcare 2021-08-31 2021-10 /pmc/articles/PMC8479031/ /pubmed/34463953 http://dx.doi.org/10.1007/s13300-021-01134-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Nakamura, Ichiro
Maegawa, Hiroshi
Tobe, Kazuyuki
Uno, Satoshi
Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM
title Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM
title_full Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM
title_fullStr Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM
title_full_unstemmed Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM
title_short Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM
title_sort correction to: safety and effectiveness of ipragliflozin in elderly versus non-elderly japanese patients with type 2 diabetes: subgroup analysis of stella-long term
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479031/
https://www.ncbi.nlm.nih.gov/pubmed/34463953
http://dx.doi.org/10.1007/s13300-021-01134-7
work_keys_str_mv AT nakamuraichiro correctiontosafetyandeffectivenessofipragliflozininelderlyversusnonelderlyjapanesepatientswithtype2diabetessubgroupanalysisofstellalongterm
AT maegawahiroshi correctiontosafetyandeffectivenessofipragliflozininelderlyversusnonelderlyjapanesepatientswithtype2diabetessubgroupanalysisofstellalongterm
AT tobekazuyuki correctiontosafetyandeffectivenessofipragliflozininelderlyversusnonelderlyjapanesepatientswithtype2diabetessubgroupanalysisofstellalongterm
AT unosatoshi correctiontosafetyandeffectivenessofipragliflozininelderlyversusnonelderlyjapanesepatientswithtype2diabetessubgroupanalysisofstellalongterm

Ejemplares similares